Literature DB >> 19168252

Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand.

Wichai Aekplakorn1, Supattra Srivanichakorn, Somkiat Sangwatanaroj.   

Abstract

OBJECTIVE: To determine the prevalence of microalbuminuria and associated risk factors in patients with type 2 diabetes in primary care.
METHODS: Clinical information of diabetic patients in 70 primary care units in Thailand was collected in a cross-sectional survey. Multinomial logistic regression model was used to examine several clinical risk factors with microalbuminuria and macroalbuminuria.
RESULTS: A total of 4162 patients were included. The prevalence of microalbuminuria was 39.12% and macroalbumninuria was 7.83%. The proportion of patients with HbA1c<7% was 37.9%. Independent risk factors for microalbuminuria and macroalbuminuria included HbA1c (adjusted OR 1.54, 95%CI 1.30-1.83 and 2.06, 95%CI 1.49-2.84 per unit increase in HbA1c, respectively), triglyceride >/=1.7mmol/L (1.31, 1.11-1.56 and 1.44, 1.06-1.98), hypertension (1.31, 1.10-1.54 and 1.64, 1.23-2.20), and duration of diabetes >/=5 years (1.31, 1.11-1.55 and 2.39, 1.74-3.28). Metabolic syndrome was associated with macroalbuminuria (OR 1.36, 95%CI 1.01-1.84).
CONCLUSION: The high prevalence of microabuminuria and suboptimal glycemic control for the diabetic patients were found to highlight the need to improve in control of glycemia and metabolic risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19168252     DOI: 10.1016/j.diabres.2008.12.020

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Cigarette smoking and risk of albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies.

Authors:  Haili Xu; Jinliu Suo; Jing Lian
Journal:  Int Urol Nephrol       Date:  2018-02-23       Impact factor: 2.370

2.  Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.

Authors:  Benja Muktabhant; Pattara Sanchaisuriya; Pongdech Sarakarn; Worawitaya Tawityanon; Mantana Trakulwong; Songsri Worawat; Frank P Schelp
Journal:  BMC Public Health       Date:  2012-05-14       Impact factor: 3.295

3.  Factors Associated With Serum Albumin in Diabetes Mellitus Type 2 With Microalbuminuria Using Non-Normal Mixed Models: A Prospective Cohort Study.

Authors:  Batoul Khoundabi; Anoshirvan Kazemnejad; Marjan Mansourian; Elham Faghihimani
Journal:  Iran Red Crescent Med J       Date:  2016-01-02       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.